Abstract

ABC transporters are conserved in prokaryotes and eukaryotes, with humans expressing 48 transporters divided into 7 classes (ABCA, ABCB, ABCC, ABCD, ABDE, ABCF, and ABCG). Throughout the human body, ABC transporters regulate cAMP levels, chloride secretion, lipid transport, and anti-oxidant responses. We used a bioinformatic approach complemented with in vitro experimental methods for validation of the 48 known human ABC transporters in airway epithelial cells using bronchial epithelial cell gene expression datasets available in NCBI GEO from well-characterized patient populations of healthy subjects and individuals that smoke cigarettes, or have been diagnosed with COPD or asthma, with validation performed in Calu-3 airway epithelial cells. Gene expression data demonstrate that ABC transporters are variably expressed in epithelial cells from different airway generations, regulated by cigarette smoke exposure (ABCA13, ABCB6, ABCC1, and ABCC3), and differentially expressed in individuals with COPD and asthma (ABCA13, ABCC1, ABCC2, ABCC9). An in vitro cell culture model of cigarette smoke exposure was able to recapitulate select observed in situ changes. Our work highlights select ABC transporter candidates of interest and a relevant in vitro model that will enable a deeper understanding of the contribution of ABC transporters in the respiratory mucosa in lung health and disease.

Details

Title
The impact of cigarette smoke exposure, COPD, or asthma status on ABC transporter gene expression in human airway epithelial cells
Author
Aguiar, Jennifer A 1   VIAFID ORCID Logo  ; Tamminga, Andrea 1 ; Lobb Briallen 1 ; Huff, Ryan D 2 ; Nguyen, Jenny P 3 ; Kim Yechan 3 ; Dvorkin-Gheva Anna 4 ; Stampfli, Martin R 5 ; Doxey, Andrew C 1 ; Hirota, Jeremy A 6   VIAFID ORCID Logo 

 University of Waterloo, Department of Biology, Waterloo, Canada (GRID:grid.46078.3d) (ISNI:0000 0000 8644 1405) 
 University of British Columbia, Division of Respiratory Medicine, Department of Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 McMaster University, Firestone Institute for Respiratory Health – Division of Respirology, Department of Medicine, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
 McMaster University, McMaster Immunology Research Centre, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
 McMaster University, Firestone Institute for Respiratory Health – Division of Respirology, Department of Medicine, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, McMaster Immunology Research Centre, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
 University of Waterloo, Department of Biology, Waterloo, Canada (GRID:grid.46078.3d) (ISNI:0000 0000 8644 1405); University of British Columbia, Division of Respiratory Medicine, Department of Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830); McMaster University, Firestone Institute for Respiratory Health – Division of Respirology, Department of Medicine, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, McMaster Immunology Research Centre, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); McMaster University, Department of Medicine, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
Publication year
2019
Publication date
Jan 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2168168713
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.